MSCs delivering LIGHT prime immune response against CAFs to harness antigen loss variants

Cancer Gene Therapy 2026

View at publisher

Authors: Weibin Zou, Linbing Zou, Wei Guo

DOI: 10.1038/s41417-026-01009-8

Cited by: 0

References: 35

Fields of Study & Subjects

Immunotherapy and Immune Responses Mesenchymal stem cell research Cancer Research and Treatments

References 35